GUARDANT HEALTH, INC. (GH) Shareholder Equity
- 2026-06-30: Additional Paid in CapitalUSD $3.01B; Treasury Stock, ValueUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-5.56M; Retained Earnings (Accumulated Deficit)USD $-3.23B.
- 2026-03-31: Additional Paid in CapitalUSD $2.93B; Treasury Stock, ValueUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-5.15M; Retained Earnings (Accumulated Deficit)USD $-3.11B.
- 2025-12-31: Additional Paid in CapitalUSD $2.90B; Treasury Stock, ValueUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-4.85M; Retained Earnings (Accumulated Deficit)USD $-2.99B.
- 2025-09-30: Additional Paid in CapitalUSD $2.56B; Treasury Stock, ValueUSD $45.01M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-4.26M; Retained Earnings (Accumulated Deficit)USD $-2.87B.
GUARDANT HEALTH, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Additional Paid in Capital USD | Treasury Stock, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Preferred Stock, Value, Outstanding USD | Common Stock, Value, Outstanding USD | Treasury Stock, Common, Shares shares | Treasury Stock, Value, Acquired, Cost Method USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Noncontrolling Interest in Net Income (Loss) Joint Venture Partners, Redeemable USD | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.01B | (m) | $-5.56M | $-3.23B | $-222.87M | $0.00 | $1.00K | (m) | (m) | (m) | 3 month · $57.73M 6 month · $105.33M | (m) | (m) |
| 2026-03-31 | $2.93B | (m) | $-5.15M | $-3.11B | $-181.07M | $0.00 | $1.00K | (m) | (m) | (m) | 3 month · $47.61M | (m) | (m) |
| 2025-12-31 | $2.90B | (m) | $-4.85M | $-2.99B | $-99.31M | $0.00 | $1.00K | (m) | 12 month · $45.01M | 12 month · $17.67M | 12 month · $166.22M | (m) | (m) |
| 2025-09-30 | $2.56B | $45.01M | $-4.26M | $-2.87B | $-354.47M | $0.00 | $1.00K | 976.35K | 9 month · $45.01M | (m) | 3 month · $42.81M 9 month · $123.03M | (m) | (m) |
| 2025-06-30 | $2.52B | $45.01M | $-3.72M | $-2.77B | $-305.48M | $0.00 | $1.00K | 976.35K | 6 month · $45.01M | (m) | 3 month · $42.46M 6 month · $80.22M | (m) | (m) |
| 2025-03-31 | $2.47B | $45.01M | $-4.66M | $-2.67B | $-250.79M | $0.00 | $1.00K | 976.35K | 3 month · $45.01M | (m) | 1 month · $5.50M 3 month · $37.76M | (m) | (m) |
| 2025-02-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · $45.00M | (m) | (m) | (m) | (m) |
| 2024-12-31 | $2.44B | $0.00 | $-5.20M | $-2.58B | $-139.65M | $0.00 | $1.00K | (m) | (m) | (m) | 12 month · $140.41M | (m) | (m) |
| 2024-09-30 | $2.41B | (m) | $-3.28M | $-2.47B | $-60.10M | $0.00 | $1.00K | (m) | (m) | (m) | 3 month · $49.77M 9 month · $104.05M | (m) | (m) |
| 2024-06-30 | $2.36B | (m) | $-5.64M | $-2.36B | $-1.61M | $0.00 | $1.00K | (m) | (m) | (m) | 3 month · $27.23M 6 month · $54.28M | (m) | (m) |
| 2024-03-31 | $2.33B | (m) | $-4.80M | $-2.26B | $68.28M | $0.00 | $1.00K | (m) | (m) | (m) | 3 month · $27.04M | (m) | (m) |
| 2023-12-31 | $2.30B | (m) | $-3.67M | $-2.14B | $158.68M | $0.00 | $1.00K | (m) | (m) | 1 month · $90.60M 12 month · $21.13M | 12 month · $90.76M | (m) | (m) |
| 2023-09-30 | $2.19B | (m) | $-5.68M | $-1.95B | $228.30M | $0.00 | $1.00K | (m) | (m) | 9 month · $21.13M | 3 month · $21.82M 9 month · $66.44M | (m) | (m) |
| 2023-06-30 | $2.17B | (m) | $-8.47M | $-1.87B | $292.73M | $0.00 | $1.00K | (m) | (m) | 3 month · $21.13M 6 month · $21.13M | 3 month · $22.35M 6 month · $44.62M | (m) | (m) |
| 2023-05-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · $21.10M | (m) | (m) | (m) |
| 2023-03-31 | $1.76B | (m) | $-12.15M | $-1.80B | $-44.55M | $0.00 | $1.00K | (m) | (m) | (m) | 3 month · $22.27M | (m) | (m) |
| 2022-12-31 | $1.74B | (m) | $-19.52M | $-1.66B | $60.18M | $0.00 | $1.00K | (m) | (m) | (m) | 12 month · $94.69M | (m) | (m) |
| 2022-09-30 | $1.72B | (m) | $-26.85M | $-1.52B | $166.75M | $0.00 | $1.00K | (m) | (m) | (m) | 3 month · $20.64M 9 month · $70.98M | (m) | (m) |
| 2022-06-30 | $1.70B | (m) | $-24.26M | $-1.36B | $319.09M | $0.00 | $1.00K | (m) | (m) | (m) | 3 month · $25.54M 6 month · $50.34M | (m) | (m) |
| 2022-03-31 | $1.68B | (m) | $-18.31M | $-1.13B | $533.04M | $0.00 | $1.00K | (m) | (m) | (m) | 3 month · $24.80M | (m) | (m) |
| 2021-12-31 | $1.66B | (m) | $-4.76M | $-1.01B | $645.00M | $0.00 | $1.00K | (m) | (m) | (m) | 12 month · $151.45M | (m) | (m) |
| 2021-09-30 | $1.63B | (m) | $-593.00K | $-916.91M | $709.42M | (m) | $1.00K | (m) | (m) | (m) | 3 month · $35.02M 9 month · $124.59M | (m) | (m) |
| 2021-06-30 | $1.60B | (m) | $33.00K | $-809.39M | $788.07M | (m) | $1.00K | (m) | (m) | (m) | 3 month · $34.51M 6 month · $89.58M | (m) | (m) |
| 2021-03-31 | $1.56B | (m) | $904.00K | $-711.81M | $847.05M | (m) | $1.00K | (m) | (m) | (m) | 3 month · $55.07M | (m) | (m) |
| 2020-12-31 | $1.90B | (m) | $2.70M | $-606.59M | $1.30B | $0.00 | $1.00K | (m) | (m) | 12 month · $1.13M | 12 month · $144.11M | (m) | 12 month · $330.40M |
| 2020-09-30 | $1.60B | (m) | $3.86M | $-512.85M | $1.09B | (m) | $1.00K | (m) | (m) | 9 month · $1.13M | 3 month · $55.20M 9 month · $87.35M | (m) | (m) |
| 2020-06-30 | $1.54B | (m) | $5.39M | $-435.18M | $1.11B | (m) | $1.00K | (m) | (m) | 3 month · $1.13M 6 month · $1.13M | 3 month · $25.82M 6 month · $32.15M | (m) | (m) |
| 2020-03-31 | $1.16B | (m) | $7.71M | $-380.54M | $785.11M | (m) | $1.00K | (m) | (m) | (m) | 3 month · $6.34M | (m) | (m) |
| 2019-12-31 | $1.15B | (m) | $1.11M | $-352.81M | $798.39M | $0.00 | $1.00K | (m) | (m) | 12 month · $723.00K | 12 month · $16.95M | 12 month · $-3.90M | (m) |
| 2019-09-30 | $1.14B | (m) | $1.11M | $-327.60M | $815.40M | (m) | $1.00K | (m) | (m) | 9 month · $723.00K | 3 month · $5.48M 9 month · $11.88M | (m) | (m) |
| 2019-06-30 | $1.13B | (m) | $1.34M | $-314.81M | $815.47M | (m) | $1.00K | (m) | (m) | 3 month · $723.00K 6 month · $723.00K | 3 month · $3.21M 6 month · $6.40M | (m) | (m) |
| 2019-03-31 | $771.01M | (m) | $333.00K | $-303.21M | $468.13M | (m) | $1.00K | (m) | (m) | (m) | 3 month · $3.18M | (m) | (m) |
| 2019-01-01 | (m) | (m) | (m) | $-275.89M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $764.03M | (m) | $-83.00K | $-280.80M | $483.15M | $0.00 | $1.00K | (m) | (m) | 12 month · $4.47M | 12 month · $6.85M | (m) | (m) |
| 2018-09-30 | $11.42M | (m) | $-531.00K | $-255.68M | $255.19M | $499.97M | $0.00 | (m) | (m) | (m) | 3 month · $1.83M | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | $276.78M | (m) | (m) | (m) | (m) | (m) | 3 month · $1.18M | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | $296.85M | (m) | (m) | (m) | (m) | (m) | 3 month · $1.28M | (m) | (m) |
| 2017-12-31 | $4.90M | (m) | $-532.00K | $-195.74M | $308.61M | $0.00 | $0.00 | (m) | (m) | (m) | 12 month · $3.67M | (m) | (m) |
| 2016-12-31 | (m) | (m) | (m) | (m) | $79.70M | (m) | (m) | (m) | (m) | (m) | 12 month · $283.00K | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | (m) | $83.44M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |